Literature DB >> 26936935

Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.

Polina Weitzenfeld1, Olga Kossover2, Cindy Körner3, Tsipi Meshel1, Stefan Wiemann3, Dror Seliktar2, Daniel F Legler4, Adit Ben-Baruch5.   

Abstract

Chemokine axes have been shown to mediate site-specific metastasis in breast cancer, but their relevance to different subtypes has been hardly addressed. Here, with the focus on the CCR7-CCL21 axis, patient datasets demonstrated that luminal-A tumors express relatively low CCR7 levels compared with more aggressive disease subtypes. Furthermore, lymph node metastasis was not associated with high CCR7 levels in luminal-A patients. The metastatic pattern of luminal-A breast tumors may be influenced by the way luminal-A tumor cells interpret signals provided by factors of the primary tumor microenvironment. Thus, CCR7-expressing human luminal-A cells were stimulated simultaneously by factors representing 3 tumor microenvironment arms typical of luminal-A tumors, hormonal, inflammatory, and growth stimulating: estrogen + TNF-α + epidermal growth factor. Such tumor microenvironment stimulation down-regulated the migration of CCR7-expressing tumor cells toward CCL21 and inhibited the formation of directional protrusions toward CCL21 in a novel 3-dimensional hydrogel system. CCL21-induced migration of CCR7-expressing tumor cells depended on PI3K and MAPK activation; however, when CCR7-expressing cancer cells were prestimulated by tumor microenvironment factors, CCL21 could not effectively activate these signaling pathways. In vivo, pre-exposure of the tumor cells to tumor microenvironment factors has put restraints on CCL21-mediated lymph node-homing cues and shifted the metastatic pattern of CCR7-expressing cells to the aggressive phenotype of dissemination to bones. Several of the aspects were also studied in the CXCR4-CXCL12 system, demonstrating similar patient and in vitro findings. Thus, we provide novel evidence to subtype-specific regulation of the CCR7-CCL21 axis, with more general implications to chemokine-dependent patterns of metastatic spread, revealing differential regulation in the luminal-A subtype. © Society for Leukocyte Biology.

Entities:  

Keywords:  CCL21; CXCR4-CXCL12 axis; bone metastasis; lymph node metastasis; migration

Mesh:

Substances:

Year:  2016        PMID: 26936935     DOI: 10.1189/jlb.3MA0815-373R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

1.  The molecular basis of breast cancer pathological phenotypes.

Authors:  Yujing J Heng; Susan C Lester; Gary Mk Tse; Rachel E Factor; Kimberly H Allison; Laura C Collins; Yunn-Yi Chen; Kristin C Jensen; Nicole B Johnson; Jong Cheol Jeong; Rahi Punjabi; Sandra J Shin; Kamaljeet Singh; Gregor Krings; David A Eberhard; Puay Hoon Tan; Konstanty Korski; Frederic M Waldman; David A Gutman; Melinda Sanders; Jorge S Reis-Filho; Sydney R Flanagan; Deena Ma Gendoo; Gregory M Chen; Benjamin Haibe-Kains; Giovanni Ciriello; Katherine A Hoadley; Charles M Perou; Andrew H Beck
Journal:  J Pathol       Date:  2016-12-29       Impact factor: 7.996

Review 2.  Circulating Tumor Cells: Does Ion Transport Contribute to Intravascular Survival, Adhesion, Extravasation, and Metastatic Organotropism?

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 3.  C-C Chemokine Receptor 7 in Cancer.

Authors:  Colin A Bill; Christopher M Allen; Charlotte M Vines
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

4.  Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells.

Authors:  Shalom Lerrer; Yulia Liubomirski; Alexander Bott; Khalid Abnaof; Nino Oren; Afsheen Yousaf; Cindy Körner; Tsipi Meshel; Stefan Wiemann; Adit Ben-Baruch
Journal:  Front Immunol       Date:  2017-05-11       Impact factor: 7.561

5.  Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma.

Authors:  Sultan N Sonbul; Kylie L Gorringe; Mohammed A Aleskandarany; Abhik Mukherjee; Andrew R Green; Ian O Ellis; Emad A Rakha
Journal:  J Pathol Clin Res       Date:  2017-03-30

6.  Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.

Authors:  Polina Weitzenfeld; Tsipi Meshel; Adit Ben-Baruch
Journal:  Oncotarget       Date:  2016-12-06

7.  Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation.

Authors:  Aerken Maolake; Kouji Izumi; Ariunbold Natsagdorj; Hiroaki Iwamoto; Suguru Kadomoto; Tomoyuki Makino; Renato Naito; Kazuyoshi Shigehara; Yoshifumi Kadono; Kaoru Hiratsuka; Guzailinuer Wufuer; Kent L Nastiuk; Atsushi Mizokami
Journal:  Cancer Sci       Date:  2018-04-29       Impact factor: 6.716

Review 8.  The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression.

Authors:  Balsam Rizeq; Mohammed Imad Malki
Journal:  Cancers (Basel)       Date:  2020-04-23       Impact factor: 6.639

9.  Fibrosis of mesothelial cell-induced peritoneal implantation of ovarian cancer cells.

Authors:  Jinou Wang; Chang Liu; Xiaoying Chang; Yafei Qi; Zhi Zhu; Xianghong Yang
Journal:  Cancer Manag Res       Date:  2018-12-04       Impact factor: 3.989

Review 10.  Alterations of Signaling Pathways Related to the Immune System in Breast Cancer: New Perspectives in Patient Management.

Authors:  Andrea Nicolini; Paola Ferrari; Lucrezia Diodati; Angelo Carpi
Journal:  Int J Mol Sci       Date:  2018-09-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.